AQUESTIVE Trademark
Trademark Overview
On Tuesday, March 11, 2025, a trademark application was filed for AQUESTIVE with the United States Patent and Trademark Office. The USPTO has given the AQUESTIVE trademark a serial number of 99078356. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, August 13, 2025. This trademark is owned by Aquestive Therapeutics, Inc.. The AQUESTIVE trademark is filed in the Treatment & Processing of Materials Services, Transportation & Storage Services, and Computer & Software Services & Scientific Services categories with the following description:
Manufacturing services for others in the field of pharmaceutical, nutritional, and topical products
Merchandise packaging for others; Co-packing services in the nature of merchandise packaging for others; Contract packaging services in the nature of merchandise packaging for others
Research and development of pharmaceutical preparations and medicines; Conducting early evaluations in the field of new pharmaceuticals; Medical and scientific research in the fields of pharmaceuticals, medicine, and therapeutics; Consulting services in the fields of pharmaceutical research and development
General Information
| Serial Number | 99078356 |
| Word Mark | AQUESTIVE |
| Filing Date | Tuesday, March 11, 2025 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Wednesday, August 13, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Manufacturing services for others in the field of pharmaceutical, nutritional, and topical products |
| Goods and Services | Merchandise packaging for others; Co-packing services in the nature of merchandise packaging for others; Contract packaging services in the nature of merchandise packaging for others |
| Goods and Services | Research and development of pharmaceutical preparations and medicines; Conducting early evaluations in the field of new pharmaceuticals; Medical and scientific research in the fields of pharmaceuticals, medicine, and therapeutics; Consulting services in the fields of pharmaceutical research and development |
Classification Information
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, March 11, 2025 |
| Primary Code | 040 |
| First Use Anywhere Date | Monday, January 1, 2018 |
| First Use In Commerce Date | Monday, January 1, 2018 |
| International Class | 039 - Transport; packaging and storage of goods; travel arrangement. |
| US Class Codes | 100, 105 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, March 11, 2025 |
| Primary Code | 039 |
| First Use Anywhere Date | Monday, July 31, 2023 |
| First Use In Commerce Date | Monday, July 31, 2023 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, March 11, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | Monday, January 1, 2018 |
| First Use In Commerce Date | Monday, January 1, 2018 |
Trademark Owner History
| Party Name | Aquestive Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Warren, NJ 07059 |
Trademark Events
| Event Date | Event Description |
| Tuesday, March 11, 2025 | NEW APPLICATION ENTERED |
| Tuesday, March 11, 2025 | APPLICATION FILING RECEIPT MAILED |
| Thursday, July 10, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, August 12, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, August 13, 2025 | NON-FINAL ACTION E-MAILED |
| Wednesday, August 13, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, August 13, 2025 | NON-FINAL ACTION WRITTEN |
